The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Osmohale, inhalation powder, hard capsule

0/5 mg/10 mg/20mg/40
milligram(s) Inhalation Powder, Capsule


Pharmaxis Europe LimitedPA22655/001/001

Main Information

Trade NameOsmohale, inhalation powder, hard capsule
Active SubstancesMannitol
Strength0/5 mg/10 mg/20mg/40
milligram(s)
Dosage FormInhalation Powder, Capsule
Licence HolderPharmaxis Europe Limited
Licence NumberPA22655/001/001

Group Information

ATC CodeV04CX Other diagnostic agents

Status

Authorised/WithdrawnAuthorised
Licence Issued12/10/2007
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back